MyLRC +
Senate Bill 163
Title:
address transparency in prescription drug pricing.
Sponsors:
Senators Diedrich (prime), Castleberry, Johnson, Smith (V. J.), and Zikmund and Representatives Davis, Duba, Goodwin, Miskimins, Olson, Perry, Reed, Reimer, Smith, and Weisgram
Fiscal Notes:
DateActionAudioLocation
01/27/2022First read in Senate and referred to Senate Health and Human Services S.J. 129 N/A
02/16/2022Scheduled for hearing 3:05
02/16/2022 Senate Health and Human Services Motion to amend, Passed Amendment 163C 3:05
02/16/2022 Senate Health and Human Services Do Pass Amended, Passed, YEAS 5, NAYS 2. 3:05
02/22/2022 Senate Deferred to another day, Passed S.J. 304 N/A
02/23/2022 Senate Motion to amend, Passed S.J. 340 Amendment 163D 2:28:55
02/23/2022 Senate Do Pass Amended, Failed, YEAS 17, NAYS 17. S.J. 341 2:28:55
02/23/2022 Intent to reconsider S.J. 341 2:28:55
02/23/2022 Senate Reconsidered, Failed, YEAS 16, NAYS 19. S.J. 372 2:28:55


Amendments
Requested ByStatusIn ContextInstructionsVersion of Bill
CurdAdopted163D (PDF)  (HTML)163D(PDF)  (HTML)Senate Health and Human Services Engrossed
Previous Amendments
Requested ByStatusIn ContextInstructionsVersion of Bill
DiedrichAdopted163C (PDF)  (HTML)163C(PDF)  (HTML)Introduced
DiedrichN/A163A (PDF)  (HTML)163A(PDF)  (HTML)Introduced